Rinvoq bags FDA green light

19th August 2019 Uncategorised 0

In the SELECT programme, the oral JAK inhibitor met all primary and ranked secondary endpoints across a variety of rheumatoid arthritis patients.

More: Rinvoq bags FDA green light
Source: News